Report me for selling fake medicine? Why are you crying when your illness relapses?

Whether the problem is discovered after the acquisition or after the listing, the consequences will be very serious. The later the discovery, the greater the loss.

At that time, if this bomb explodes, Pfizer may be stunned.

The company Elsilan hid the problems so much that it even modified the reports to cover up the problems in the clinical trials.

This shows that the problem is so serious that they dare not expose it. Instead, they want to cash out as soon as possible, which is why they need to revise this report.

If Pfizer fails to discover the problem, the blame will be shifted to Pfizer. As for the Elsheland team, they might just get the money and run away.

After thinking of this possibility, Chen Xuan couldn't help but smile.

He didn't expect that his momentary curiosity would lead to such a huge unexpected gain.

This matter is becoming more and more interesting.

……

A few days later!

Today, Antai Pharmaceutical Group is once again bustling with activity.

This is because the phase III clinical trial of a special drug for lung cancer is about to end today.

Once the Phase III clinical trial is completed, it means that the effective drug for lung cancer will be officially launched on the market soon.

Therefore, countless reporters once again focused their attention on Antai Pharmaceutical Group, and it also attracted the attention of countless patients, who are all looking forward to the early launch of this special drug for lung cancer.

This new drug has become the hope, or even the only hope, for most lung cancer patients to survive.

Most importantly, the price of lung cancer-specific drugs is relatively cheap, which makes countless patients look forward to the launch of new drugs day and night.

At the same time, CCTV also came to interview and help promote the special medicine for lung cancer.

So, this day was really lively.

The huge lobby was already full of people.

"Today marks the end of the Phase III clinical trial of a lung cancer drug."

"From the first day of the clinical trial to today, a lot has happened, and there have been many twists and turns."

"Fortunately, all the problems have been resolved. The lung cancer drug has been proven to be effective and safe in phase III clinical trials, and multiple indications have been discovered."

Chen Xuan stood on the podium and announced to the audience, "The results of all the tests have exceeded expectations, proving that this lung cancer drug is safe and effective, suitable for large-scale application."

As soon as the words fell, the whole audience suddenly boiled over.

Although everyone who participated in this event today had already known the news in advance,

But when I heard him say it himself, I still felt extremely excited.

Because the lung cancer specific drug is China's first anti-cancer drug and the only specific drug that can cure lung cancer.

This alone is enough to excite countless Chinese people, and the most anticipated are lung cancer patients, as this is their only hope of survival.

"Mr. Chen, the Phase III clinical trial has ended."

"Patients participating in clinical trials have also proven that this drug is effective and can definitely cure lung cancer."

"So when will this lung cancer drug be officially available? This is news countless patients are waiting for. Can you share some information?"

At this time, CCTV host Bingbing also asked a question.

This issue, which is also the focus of today, is the time when the special medicine for lung cancer will be officially launched on the market.

Because countless lung cancer patients are waiting for this day, they are extremely eager to see effective drugs for lung cancer come to the market.

After all, patients who participated in clinical trials already have a chance to survive, but other lung cancer patients have not yet received treatment with lung cancer-specific drugs.

If they cannot obtain effective drugs for lung cancer in time, their lives will always be in danger, especially for patients with advanced lung cancer. Every day of delay increases the risk.